Form 4 Tracker
Mark Schoenberg

Chief Medical Officer · 8 filings · Latest: Sep 7, 2026

UroGen Pharma Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
URGN
Schoenberg Mark—Jun 9, 2025
Proposed Sale
$7.375,162$38.0K—
URGN
Schoenberg Mark—Sep 9, 2024
Proposed Sale
$13.23859$11.4K—

← Previous

Page 2 of 2